bioecon Member area

Platform chemicals

The fate of a bio-based chemical is decided by separation and by the buyer, not by the chemistry; petrochemical by-products are brutal competition; and biology wins against difficult synthesis, not against cracking.

9 pages
Explanatory reference: why a technology works and where the science is unsettled. Drafted with AI assistance; pages carry no per-claim references and have not yet been reviewed by a subject expert — use them for orientation, not as a citable source. The evidence for each technology, with graded sources, is in its dossier. How this reference is made →

Nine molecules that are usually listed together and ended up in four different places — which is the point of the cluster. The fate of a bio-based chemical is decided by separation and by the buyer, not by the chemistry. Lactic acid, the success case, won on three things at once: a pathway that loses no carbon, an established purification route, and a buyer who needs a specific specification. Succinate, itaconate, FDCA and BDO drew different hands.

The second recurring idea: petrochemistry’s by-product economics are brutal. Butadiene comes almost free from the cracker, so the biological route loses regardless of its quality; bio-ethylene is deployed at scale for reasons that have little to do with technical superiority; butanol, once the largest fermentation industry after ethanol, lost to a single number.

The third: biology wins where it competes with difficult organic synthesis, not with cracking — terpenes, the acrylamide process that beat metal catalysis on every axis at once, the mould without which cortisone could not be assembled.

Start with succinate, itaconate, FDCA and BDO: four fates under one label, and the evaluation framework for everything else here.

Articles 9

Microbial arachidonic acid
Why a mould oil displaced animal-derived lipid in infant formula — and why that is a specification argument rather than a cost one.
Bio-based acrylic acid
Acrylic acid cannot be fermented directly — and both detours run into the same two ceilings: carbon accounting and product toxicity.
Biocatalytic acrylamide and flocculants
The rare case where biology beat metal catalysis on every axis at once — and why this is biocatalysis, not fermentation.
Bio-based butadiene
A molecule petrochemistry gets almost for free as a by-product — and why that makes the biological route uncompetitive regardless of how good it is.
Butanol and isobutanol platforms
The twentieth century's largest fermentation industry after ethanol, lost to petrochemistry — and the one number that explains why.
Succinate, itaconate, FDCA and BDO
Four monomers routinely listed together as platform chemicals — and four different fates, decided by separation and by the buyer rather than by chemistry.
Bio-ethylene and bio-ethylene oxide
Bioethanol dehydration works and is deployed at industrial scale — for reasons that have little to do with the technology being better.
L-lactic acid at industrial scale
The cluster's success case: a pathway that loses no carbon, an established purification route, and a buyer who needs a specific specification.
Terpenes and terpenoids as platform molecules
Here biology competes with difficult organic synthesis rather than with cracking — and wins on chemistry without necessarily winning on market.